International Precision Medicine Conference
March 13-15, 2025
Personalized Medicine for COVID-19
Personalized Medicine for COVID-19
In medicine, a taxonomic revolution has taken place. The research for a precise COVID-19 treatment has already begun. Researchers have created a multitude of new disease subclassifications, fueled by the utopian vision of focused “precision” therapy and enabled by access to vast electronic health data sets, high-throughput multichannel, molecular diagnostic assays, and discoveries in disease biology. The time has come for a COVID-19 precision medicine strategy that combines translational science, subtype discovery, and a new taxonomy with clinical trial knowledge generation. The future of medicine will be shaped by personalized medicine, which places the patient at the center of attention.
- Selecting homogeneous groups of COVID-19 patients
- Heterogenous COVID-19 Population
- Precision medicine-guided trials
- Randomized controlled trial
Committee Members
Roy Gary Beran
University of New South Wales, Australia
Ewa Danuta Bialek
Institute of Psychosynthesis, Poland
Sergey Suchkov
The Russian University of Medicine & Russian Academy of Natural Sciences, Russian Federation IPMC 2022 Speakers
Jinyuan Zhou
Johns Hopkins University School of Medicine, United States
Wei Wu
UCSF, United States
Xu Chen
The College of St. Scholastica, United States
Styliani Geronikolou
University Research Institute of Maternal and Child health & Precision Medicine, Greece
Title : Precision Pharmacotherapy in the Treatment of Epilepsy - Use of Antiseizure Medications and Therapeutic Blood Level Monitoring
Roy Gary Beran, University of New South Wales, Australia
Title : When something comes on time, it is education, if too late, it is therapy. Health or disease - It is our choice
Ewa Danuta Bialek, Institute of Psychosynthesis, Poland
Title : Antibody-Proteases as translational tools of the newest generation to be applied for biodesign and bioengineering to get Precision and Personalized healthcare services Re-armed
Sergey Suchkov, The Russian University of Medicine & Russian Academy of Natural Sciences, Russian Federation
Title : Exposome for precision medicine
Styliani Geronikolou, University Research Institute of Maternal and Child health & Precision Medicine, Greece
Title : Precision Diagnostics and Medical Devices: Innovative Imaging Technologies for Lung Cancer Screening in Large Populations
Huiqin Yang, ICON Clinical Research Ltd, United Kingdom
Title : Use of indocyanine green fluorescence imaging in the extrahepatic biliary tract surgery
Orestis Ioannidis, Aristotle University of Thessaloniki, Greece